Capricor Therapeutics vs uniQure
CAPR and QURE side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CAPR and QURE compare
uniQure is the larger company, worth 2.9 times as much as Capricor Therapeutics ($1.4B against $489M).
Capricor Therapeutics scores higher on the StockData Score (6 against 4 for uniQure), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CAPR | QURE |
|---|---|---|
| Size and price | ||
| Market cap | $489M | $1.4B |
| Share price | $8.41 | $20.78 |
| Change, 1 year | 50.2% | −30.5% |
| Change, 5 years | 147% | −27.9% |
| Beta (5Y) | 0.42 | 3.14 |
| Employees | 231 | 221 |
| StockData Score | ||
| Total score | 6 (better) | 4 |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 77.2× |
| P/B | 2.0× (better) | 4.4× |
| FCF yield | −23.5% | −11.2% (better) |
| Fair value | – | $6.42 |
| Margin of safety | – | −224% |
| Growth | ||
| Revenue growth (TTM) | – | 30.2% |
| Revenue growth, 5Y average | – | −15.6% |
| Profitability | ||
| Gross margin | – | 92.5% |
| Operating margin | – | −1072% |
| Net margin | – | −1351% |
| FCF margin | – | −865% |
| Return on equity | −73.7% (better) | −158% |
| Financial health | ||
| Debt / equity | 0.00 | 0.15 (better) |
| Interest coverage | – | −3.4× |
| Current ratio | 7.35 | 10.01 (better) |
| Altman Z-score | 0.42 (better) | −0.51 |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 67.6% | 96.0% |
| Held by insiders | 1.6% | 2.1% |
| Insider net buying, 12 months | −$8.4M (better) | −$20.2M |
| Short interest, % of float | 32.8% | 12.5% |
Go deeper
- CAPR stock overview
- CAPR income statement
- CAPR valuation and score
- QURE stock overview
- QURE income statement
- QURE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.